首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1789375

複合注射劑市場：按分子類型、治療用途、產品類型、包裝類型、給藥途徑、年齡層、分銷管道、最終用戶和地區分類

Complex Injectable Market, By Molecule Type, By Therapeutic Application, By Product Type, By Packaging Type, By Route of Administration, By Age Group, By Distribution Channel, By End User, By Geography

出版日期: 2025年07月29日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

複雜注射劑市場規模預計在 2025 年達到 261.1 億美元，預計到 2032 年將達到 465 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 8.6%。

分析範圍		分析詳細資訊
基準年	2024	市場規模（2025年）	261.1億美元
效能數據	2020-2024	預測期	2025-2032
預測期間的複合年成長率（2025-2032年）	8.60%	預計金額（2032年）	465億美元

全球複雜注射劑市場是製藥業一個快速發展的領域，涵蓋需要專門製造、處理和給藥通訊協定的複雜藥物傳輸系統。複雜注射涵蓋各種產品，例如脂質體、微球、乳化、混懸液和其他先進劑型，由於其複雜的製造流程或獨特的物理化學特性，這些產品難以複製。近年來，這些產品獲得了顯著的關注，因為與傳統注射劑相比，它們具有更高的治療效果、更高的患者依從性和更精準的藥物傳遞能力。

該市場涵蓋品牌複雜學名藥和創新生技藥品，服務於腫瘤學、免疫學、心臟病學和中樞神經系統疾病等重要治療領域。慢性病發病率的上升、個人化醫療需求的不斷成長以及全球醫療保健支出的不斷成長，共同推動了該市場的顯著成長。此外，幾種重磅複雜注射藥物的專利到期，為非專利藥製造商創造了豐厚的機會，而藥物輸送系統的技術進步也持續推動著該領域的創新，使複雜注射劑成為現代醫療保健輸送系統的重要組成部分。

市場動態

全球複方注射劑市場主要受多種強勁因素驅動，這些因素持續推動其成長軌跡。癌症、糖尿病、自體免疫疾病和心血管疾病等慢性疾病的增多，推動了對先進治療方案的需求，而複方注射劑憑藉著卓越的生物利用度和標靶給藥機制，能夠提供這些方案。眾多重磅複方注射的專利懸崖為非專利製造商帶來了重大機會，他們可以透過生物相似藥和學名藥進入市場，從而擴大市場准入並降低醫療成本。藥物傳輸系統的技術進步，例如奈米技術製劑、緩釋性機制和精準醫療方法，正在推動創新並創造新的治療可能性。

全球人口老化，加上新興市場醫療支出的增加和醫療基礎設施的發展，進一步推動了市場擴張。然而，市場面臨重大阻礙，包括嚴格的監管要求，需要進行大量的臨床試驗和複雜的核准流程，以及顯著增加的開發成本和上市時間。複雜的注射藥物需要高度複雜的製造程序，需要在專門的設施和設備上進行大量的資本投資，從而設置了進入障礙。此外，這些產品的技術複雜性對實現生物等效性和確保品質一致性提出了挑戰，而有限的配方開發和監管專業知識限制了市場進入。儘管面臨這些挑戰，但也存在大量機遇，包括醫療保健的數位化、向製藥行業不斷成長的新興市場的擴張、創新者和非專利製造商之間的戰略合作夥伴關係，以及針對新型藥物輸送技術和個性化醫療機會的持續研發。

本報告的主要特點

本報告對全球複雜注射劑市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
它還強調了每個領域的潛在商機，並描述了該市場的一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球複雜注射劑市場的主要企業已根據以下參數進行了分析，例如公司概況、產品系列、主要亮點、財務表現和策略。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
「全球複雜注射劑市場」報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球複雜注射劑市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 26.11 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.60%	2032 Value Projection:	USD 46.50 Bn

The global complex injectable market represents a rapidly evolving segment of the pharmaceutical industry, encompassing sophisticated drug delivery systems that require specialized manufacturing, handling, and administration protocols. Complex injectables include a diverse range of products such as liposomes, microspheres, emulsions, suspensions, and other advanced formulations that cannot be easily replicated due to their intricate manufacturing processes and unique physicochemical properties. These products have gained significant traction in recent years as they offer enhanced therapeutic efficacy, improved patient compliance, and targeted drug delivery capabilities compared to conventional injectable formulations.

The market encompasses both branded complex generics and innovative biologics, serving critical therapeutic areas including oncology, immunology, cardiology, and central nervous system disorders. The increasing prevalence of chronic diseases, growing demand for personalized medicine, and rising healthcare expenditure globally have contributed to the substantial growth of this market. Additionally, the patent expiration of several blockbuster complex injectable drugs has created lucrative opportunities for generic manufacturers, while technological advancements in drug delivery systems continue to drive innovation in this space, making complex injectables an essential component of modern healthcare delivery systems.

Market Dynamics

The global complex injectable market is primarily driven by several compelling factors that continue to propel its growth trajectory. The increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular diseases has created substantial demand for advanced therapeutic solutions that complex injectables can provide through their superior bioavailability and targeted delivery mechanisms. Patent cliffs of numerous blockbuster complex injectable drugs have opened significant opportunities for generic manufacturers to enter the market with biosimilar and generic versions, thereby expanding market accessibility and reducing healthcare costs. Technological advancements in drug delivery systems, including nanotechnology-based formulations, sustained-release mechanisms, and precision medicine approaches, are driving innovation and creating new therapeutic possibilities.

The growing aging population worldwide, coupled with rising healthcare expenditure and improved healthcare infrastructure in emerging markets, further supports market expansion. However, the market faces notable restraints including stringent regulatory requirements that demand extensive clinical trials and complex approval processes, significantly increasing development costs and time-to-market. The highly sophisticated manufacturing processes required for complex injectables necessitate substantial capital investments in specialized facilities and equipment, creating barriers for new entrants. Additionally, the technical complexity of these products poses challenges in achieving bioequivalence and ensuring consistent quality, while limited expertise in formulation development and regulatory affairs restricts market participation. Despite these challenges, opportunities abound through increasing healthcare digitalization, expansion in emerging markets with growing pharmaceutical sectors, strategic partnerships between innovator companies and generic manufacturers, and continuous research and development efforts focused on novel drug delivery technologies and personalized medicine approaches.

Key Features of the Study

This report provides in-depth analysis of the global complex injectable market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global complex injectable market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc, Novartis AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc, Sanofi SA, GlaxoSmithKline plc, AstraZeneca PLC, Eli Lilly and Company, Amgen Inc, AbbVie Inc, Bristol Myers Squibb, Takeda Pharmaceutical Co. Ltd, Biogen Inc, and Gilead Sciences Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global complex injectable market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global complex injectable market

Market Segmentation

Molecule Type Insights (Revenue, USD Bn, 2020 - 2032)
- Small Molecule
- Biologics-Based
Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Metabolic Disorders
- Hematological Disorders
- Neurological Disorders
- Ophthalmology
- Dermatology
- Cardiovascular Diseases
- Others (Rare Diseases)
Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Monoclonal Antibodies
- Peptides and Proteins
- Antibiotics
- Chemotherapy Agents
- Hormones
- Blood Factors
- Gene Therapy Products
- Cell Therapy Products
- Others (Oligonucleotides)
Packaging Type Insights (Revenue, USD Bn, 2020 - 2032)
- Vials
- Prefilled Syringes
- Ampoules
- Cartridges
- Others (IV Bags)
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
- Intrathecal
- Intra-articular
- Other Parenteral Routes (Intradermal)
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Home Healthcare Settings
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc
- Novartis AG
- Hoffmann-La Roche Ltd
- Johnson & Johnson
- Merck & Co., Inc
- Sanofi SA
- GlaxoSmithKline plc
- AstraZeneca PLC
- Eli Lilly and Company
- Amgen Inc
- AbbVie Inc
- Bristol Myers Squibb
- Takeda Pharmaceutical Co. Ltd
- Biogen Inc
- Gilead Sciences Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Complex Injectable Market, By Molecule Type
- Global Complex Injectable Market, By Therapeutic Application
- Global Complex Injectable Market, By Product Type
- Global Complex Injectable Market, By Packaging Type
- Global Complex Injectable Market, By Route of Administration
- Global Complex Injectable Market, By Age Group
- Global Complex Injectable Market, By Distribution Channel
- Global Complex Injectable Market, By End User
- Global Complex Injectable Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Complex Injectable Market, By Molecule Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biologics-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Complex Injectable Market, By Therapeutic Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Rare Diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Complex Injectable Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Peptides and Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chemotherapy Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gene Therapy Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cell Therapy Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Oligonucleotides)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Complex Injectable Market, By Packaging Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cartridges
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (IV Bags)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Complex Injectable Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intrathecal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intra-articular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Parenteral Routes (Intradermal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Complex Injectable Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Complex Injectable Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Complex Injectable Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Complex Injectable Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

13. Competitive Landscape

Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biogen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gilead Sciences Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies